Welcome to our dedicated page for Guardian Pharmacy Services news (Ticker: GRDN), a resource for investors and traders seeking the latest updates and insights on Guardian Pharmacy Services stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Guardian Pharmacy Services's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Guardian Pharmacy Services's position in the market.
Guardian Pharmacy Services (NYSE: GRDN) reported Q3 2024 financial results with revenue of $314.4 million, up 20% year-over-year, driven by organic growth and the Heartland Pharmacy acquisition. The company's resident count increased 12% to 180,000. Despite revenue growth, Guardian reported a net loss of $105.8 million, primarily due to $122.4 million in share-based compensation expenses related to Corporate Reorganization and IPO. Adjusted EBITDA grew 20% to $23.0 million. The company provided full-year 2024 guidance projecting revenue between $1.205-1.215 billion and Adjusted EBITDA of $86.5-87.0 million.
Guardian Pharmacy Services (NYSE: GRDN), a leading long-term care pharmacy services provider, has announced its participation in the Stephens Annual Investment Conference in Nashville. The event, scheduled for November 21, 2024, will feature a fireside chat at 9:00am CT.
Investors can access the live audio webcast through the company's investor relations website, with a replay available for approximately 60 days following the event.
Guardian Pharmacy Services (NYSE: GRDN), a major long-term care pharmacy services provider, has scheduled its Q3 2024 earnings release for Tuesday, November 12, 2024, after market close. The company will host a conference call at 4:30pm ET to discuss the results. The call will be accessible via webcast at investors.guardianpharmacy.com or by phone for both U.S. and international participants. A replay will be available for approximately 60 days following the call.
Guardian Pharmacy Services announced the pricing of its upsized initial public offering (IPO) of 8,000,000 shares of Class A common stock at $14.00 per share. The company has granted underwriters a 30-day option to purchase up to 1,200,000 additional shares at the public offering price, less the underwriting discount. Trading is expected to begin on the New York Stock Exchange on September 26, 2024, under the symbol "GRDN". The offering is set to close on September 27, 2024, subject to customary conditions.
Raymond James is the lead bookrunning manager and representative of the underwriters, with Stephens Inc. and Truist Securities acting as joint bookrunning managers. A registration statement on Form S-1 for the offering was declared effective by the SEC on September 25, 2024.
FAQ
What is the current stock price of Guardian Pharmacy Services (GRDN)?
What is the market cap of Guardian Pharmacy Services (GRDN)?
